Karen P. Robards, Director at AtriCure, Inc. (ATRC), bought 2,300 shares at $3.29 ($8K) on 2009-06-16, disclosed to the SEC on 2009-06-18.
Open-market purchase of $8k ATRC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BSTZ | BUY | 2019-06-27 | $5K | — | Filing → |
| MSO | BUY | 2019-04-18 | $10K | — | Filing → |
| MSO | BUY | 2018-02-26 | $25K | — | Filing → |